18f-gp1
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2014 (NCT02469376)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f gp1
- 18f-gp1
- gp1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04156230 | Phase 2 | Nov 25, 2019 | University of Ulsan |
| NCT02864810 | Phase 1 | Aug 1, 2016 | University of Ulsan |
| NCT02469376 | Phase 1 | Sep 1, 2014 | Piramal, University of Zurich |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Ulsan | Academic/Hospital | 2 | 2 | 2 | 2016 |
| Piramal | For profit | 1 | 0 | 1 | 2014 |
| University of Zurich | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1